Recently, it was reported that the expression of miR-106a stimulates bone metastasis of lung adenocarcinoma and its expression, by reducing PTEN expression, may be a new therapeutic target for bone metastasis in adenocarcinoma (63, 64). The gene discussed is PTEN; the disease is adenocarcinoma.